P C Appelbaum

Author PubWeight™ 243.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother 2000 4.31
2 Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977 4.07
3 Enhanced detection of bacteremia with a new BACTEC resin blood culture medium. J Clin Microbiol 1983 3.25
4 Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob Agents Chemother 1994 3.12
5 Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 2000 3.00
6 Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999 2.74
7 Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin. Antimicrob Agents Chemother 1992 2.64
8 Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance study. Antimicrob Agents Chemother 1999 2.63
9 Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrob Agents Chemother 1978 2.45
10 Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes. Antimicrob Agents Chemother 1986 2.39
11 Evaluation of a two-hour method for screening pathogens from stool specimens. J Clin Microbiol 1984 2.27
12 Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother 1994 2.21
13 Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Arch Intern Med 1993 2.21
14 Pleuropulmonary infections caused by Eikenella corrodens. Rev Infect Dis 1992 2.20
15 Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob Agents Chemother 1997 2.17
16 Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995 2.13
17 Comparison of three methods for anaerobe identification. J Clin Microbiol 1983 2.12
18 Four methods for identification of gram-negative nonfermenting rods: organisms more commonly encountered in clinical specimens. J Clin Microbiol 1980 2.09
19 In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. Antimicrob Agents Chemother 1999 2.04
20 Proctitis associated with Neisseria cinerea misidentified as Neisseria gonorrhoeae in a child. J Clin Microbiol 1985 1.90
21 MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996 1.90
22 Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob Agents Chemother 1997 1.87
23 Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococci. J Clin Microbiol 1984 1.82
24 Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob Agents Chemother 1998 1.79
25 Evaluation of the rapid strep system for species identification of streptococci. J Clin Microbiol 1984 1.78
26 Evaluation of the rapid NFT system for identification of gram-negative, nonfermenting rods. J Clin Microbiol 1984 1.78
27 In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998 1.75
28 Pancreatic abscess associated with Achromobacter group Vd biovar 1. J Clin Microbiol 1980 1.75
29 Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob Agents Chemother 1998 1.73
30 Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother 2010 1.72
31 In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae. Antimicrob Agents Chemother 2000 1.70
32 Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J Antimicrob Chemother 1993 1.69
33 In vitro selection of resistance to clinafloxacin, ciprofloxacin, and trovafloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother 2000 1.62
34 Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob Agents Chemother 1997 1.61
35 Evaluation of the E-Test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992 1.59
36 Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995 1.58
37 Accuracy and reproducibility of a four-hour method for anaerobe identification. J Clin Microbiol 1985 1.54
38 Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrob Agents Chemother 1996 1.51
39 In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemother 1994 1.51
40 Identification of an erm(A) erythromycin resistance methylase gene in Streptococcus pneumoniae isolated in Greece. Antimicrob Agents Chemother 2001 1.50
41 Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. Antimicrob Agents Chemother 1994 1.49
42 Antipneumococcal activities of gemifloxacin compared to those of nine other agents. Antimicrob Agents Chemother 2000 1.49
43 Antipneumococcal activity of ABT-773 compared to those of 10 other agents. Antimicrob Agents Chemother 2000 1.48
44 Comparative antianaerobic activity of BMS 284756. Antimicrob Agents Chemother 2001 1.44
45 Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob Agents Chemother 1994 1.44
46 Pathogenic mechanisms of a non-agglutinable Vibrio cholerae strain: demonstration of invasive and enterotoxigenic properties. Infect Immun 1977 1.43
47 Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by the Asian Network for Surveillance of Resistant Pathogens (ANSORP). Clin Infect Dis 2001 1.42
48 Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J Clin Microbiol 1996 1.41
49 Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. Antimicrob Agents Chemother 1997 1.37
50 Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. J Clin Microbiol 1993 1.36
51 Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 2000 1.34
52 Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. Antimicrob Agents Chemother 1996 1.34
53 Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother 2001 1.33
54 Comparison of three methods for identification of Enterobacteriaceae. Eur J Clin Microbiol 1982 1.32
55 Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. J Antimicrob Chemother 1990 1.31
56 Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology. J Antimicrob Chemother 1996 1.27
57 Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis 2001 1.25
58 Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996 1.24
59 Transduction of R factors in Proteus mirabilis and P. rettgeri. J Gen Microbiol 1973 1.23
60 Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother 1994 1.23
61 Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). Antimicrob Agents Chemother 1997 1.22
62 Neonatal septicemia and meningitis due to Aeromonas shigelloides. J Pediatr 1978 1.21
63 Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies. J Clin Microbiol 2000 1.20
64 Septicemia due to Capnocytophaga (Bacteroides ocharaceus) in Hodgkin's disease. Ann Intern Med 1979 1.19
65 Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Clin Infect Dis 1997 1.19
66 Disseminated Mycobacterium marinum infection and bacteremia in a child with severe combined immunodeficiency. Clin Infect Dis 1995 1.19
67 Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob Agents Chemother 1996 1.18
68 Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrob Agents Chemother 1998 1.18
69 Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology. Antimicrob Agents Chemother 1997 1.16
70 Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob Agents Chemother 2000 1.16
71 Accuracy and reproducibility of the 4-hour ATB 32A method for anaerobe identification. J Clin Microbiol 1989 1.15
72 Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin. Antimicrob Agents Chemother 1993 1.14
73 Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole. Antimicrob Agents Chemother 1997 1.12
74 Evaluation of the four-hour Micro-ID technique for direct identification of oxidase-negative, Gram-negative rods from blood cultures. J Clin Microbiol 1980 1.12
75 MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Antimicrob Agents Chemother 1997 1.12
76 Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies. J Clin Microbiol 1995 1.12
77 Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin. Antimicrob Agents Chemother 1994 1.11
78 Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents. Antimicrob Agents Chemother 2003 1.11
79 Placental microbiology and histology and the pathogenesis of chorioamnionitis. Obstet Gynecol 1984 1.10
80 Molecular characterization of multidrug-resistant Streptococcus pneumoniae isolates in Korea. The Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group. J Clin Microbiol 2000 1.10
81 Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother 1997 1.09
82 Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 1998 1.09
83 Postantibiotic effect of sanfetrinem compared with those of six other agents against 12 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1997 1.09
84 Antipneumococcal activity of BAY 12-8039, a new quinolone, compared with activities of three other quinolones and four oral beta-lactams. Antimicrob Agents Chemother 1997 1.08
85 Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents. Antimicrob Agents Chemother 2001 1.07
86 Evaluation of RapID onE system for identification of 379 strains in the family Enterobacteriaceae and oxidase-negative, gram-negative nonfermenters. J Clin Microbiol 1994 1.07
87 Accuracy and reproducibility of the IDS rapID STR system for species identification of streptococci. J Clin Microbiol 1986 1.06
88 Opportunistic infection of chronic skin ulcers with Pseudomonas putrefaciens. Br J Dermatol 1978 1.05
89 Spread of multidrug-resistant Streptococcus pneumoniae in South Korea. Clin Infect Dis 1997 1.05
90 Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. J Antimicrob Chemother 1999 1.05
91 Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. J Antimicrob Chemother 1997 1.04
92 Comparative activities of clinafloxacin against gram-positive and -negative bacteria. Antimicrob Agents Chemother 1998 1.03
93 Unsuccessful pregnancies--report on 200 perinatal postmortems. S Afr Med J 1978 1.03
94 Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 2008 1.02
95 Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay. Antimicrob Agents Chemother 1998 1.02
96 Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome. J Antimicrob Chemother 1986 1.01
97 Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology. Antimicrob Agents Chemother 1998 1.01
98 Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother 1996 1.01
99 Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam. Chemotherapy 1983 1.01
100 Meningitis caused by Streptococcus dysgalactiae in a preterm infant. Am J Clin Pathol 1978 1.01
101 Shigella infection in African and Indian children with special reference to Shigella septicemia. J Pediatr 1978 1.00
102 Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms. Antimicrob Agents Chemother 2006 1.00
103 The spectrum of infection and sensitivity of organisms isolated from African and Indian children in a Durban hospital. Trans R Soc Trop Med Hyg 1978 1.00
104 Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods. Antimicrob Agents Chemother 1997 1.00
105 gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains. Antimicrob Agents Chemother 2001 1.00
106 Comparison of two methods for same-day identification of Enterobacteriaceae. Am J Clin Pathol 1982 0.99
107 Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1998 0.99
108 Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996 0.98
109 Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. J Antimicrob Chemother 2001 0.98
110 How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay? Clin Infect Dis 1993 0.98
111 Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics. Eur J Clin Microbiol 1982 0.97
112 Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2. J Antimicrob Chemother 1998 0.97
113 MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996 0.97
114 Septicaemia in kwashiorkor. S Afr Med J 1978 0.96
115 Postantibiotic effects of telavancin against 16 gram-positive organisms. Antimicrob Agents Chemother 2009 0.96
116 Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin Infect Dis 2000 0.96
117 Comparison of three methods for identification of pathogenic Neisseria species. J Clin Microbiol 1979 0.95
118 Penicillin-resistant pneumococcus and meningitis. Ann Intern Med 1983 0.95
119 Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants. Am J Obstet Gynecol 1993 0.95
120 Evaluation of the 4-hour RapID NF Plus method for identification of 345 gram-negative nonfermentative rods. J Clin Microbiol 1992 0.95
121 Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers. Clin Microbiol Infect 2003 0.95
122 Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrob Agents Chemother 2001 0.95
123 Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are high. Antimicrob Agents Chemother 1999 0.94
124 Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococci. Eur J Clin Microbiol Infect Dis 1993 0.94
125 Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms. Antimicrob Agents Chemother 1998 0.94
126 beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis 1992 0.94
127 A randomized clinical study of cefoperazone and sulbactam versus gentamicin and clindamycin in the treatment of intra-abdominal infections. J Antimicrob Chemother 1990 0.93
128 Salmonella meningitis in infants. Lancet 1977 0.93
129 Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria. Antimicrob Agents Chemother 1994 0.92
130 Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies. J Clin Microbiol 1998 0.92
131 Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria. Antimicrob Agents Chemother 2000 0.91
132 Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn Microbiol Infect Dis 1999 0.91
133 Pyelonephritis and septicemia due to gram-positive rods similar to Corynebacterium group E (aerotolerant Bifidobacterium adolescentis). Ann Intern Med 1980 0.91
134 Penicillinase-producing Neisseria gonorrhoeae from South Africa. Lancet 1977 0.91
135 Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel. Int J Antimicrob Agents 2000 0.90
136 Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe. Clin Microbiol Infect 2003 0.90
137 Transductional analysis of non-motile mutants in Proteus mirabilis. J Gen Microbiol 1973 0.89
138 Evaluation of Gram-stain screen and Micro-ID methods for direct identification of Enterobacteriaceae from urines. Med Microbiol Immunol 1982 0.89
139 Fatal pneumococcal bacteremia in a vaccinated splenectomized child. N Engl J Med 1979 0.88
140 A flagellar phage for the proteus-providence group. J Gen Virol 1971 0.88
141 Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob Agents Chemother 2004 0.88
142 Metronidazole in the prophylaxis and treatment of anaerobic infection. S Afr Med J 1978 0.87
143 Postantibiotic effects of gatifloxacin against gram-positive and -negative organisms. Antimicrob Agents Chemother 1999 0.87
144 Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis. Clin Microbiol Infect 2003 0.86
145 Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole. Diagn Microbiol Infect Dis 2000 0.86
146 Postantibiotic effects of garenoxacin (BMS-284756) against 12 gram-positive or -negative organisms. Antimicrob Agents Chemother 2003 0.86
147 Postantibiotic effect of DX-619 against 16 gram-positive organisms. Antimicrob Agents Chemother 2005 0.86
148 The presence of amniotic fluid leukoattractants accurately identifies histologic chorioamnionitis and predicts tocolytic efficacy in patients with idiopathic preterm labor. Am J Obstet Gynecol 1992 0.86
149 Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. Eur J Clin Microbiol Infect Dis 1990 0.86
150 Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams. J Antimicrob Chemother 1997 0.86
151 Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms. Antimicrob Agents Chemother 1998 0.86
152 Amniotic fluid leukotaxis assay as an early indicator of chorioamnionitis. Am J Obstet Gynecol 1989 0.85
153 Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrob Agents Chemother 1994 0.85
154 Postantibiotic effect of ceftaroline against gram-positive organisms. Antimicrob Agents Chemother 2009 0.85
155 Sensitivity of Acinetobacter calcoaceticus strains to seven cephalosporins. Lancet 1981 0.84
156 Genetic analysis of serotype 23F Streptococcus pneumoniae isolates from several countries by penicillin-binding protein gene fingerprinting and pulsed-field gel electrophoresis. Chemotherapy 1999 0.84
157 Comparison of four methods for identification of gram-negative non-fermenters: organisms less commonly encountered in clinical specimens. Med Microbiol Immunol 1981 0.83
158 Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology. Antimicrob Agents Chemother 1998 0.83
159 Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. Antimicrob Agents Chemother 1999 0.83
160 Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates. Antimicrob Agents Chemother 2003 0.82
161 Hepatobiliary infections caused by Haemophilus species. Clin Infect Dis 1992 0.82
162 The effect of diet supplementation and addition of zinc in vitro on the growth-supporting property of amniotic fluid in African women. Am J Obstet Gynecol 1979 0.82
163 Aztreonam compared with gentamicin for treatment of serious urinary tract infections. Lancet 1984 0.82
164 Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae. J Antimicrob Chemother 1999 0.81
165 Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries. Laser Study Group. Int J Antimicrob Agents 2000 0.81
166 Septicemia due to Streptococcus equisimilis in a child with acute lymphoblastic leukemia. Cancer 1979 0.81
167 Vertebral disc space infection and osteomyelitis due to Candida albicans in a patient with acute myelomonocytic leukemia. Cancer 1980 0.81
168 Multidrug-resistant Streptococcus pneumoniae from India. Lancet 2002 0.81
169 Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedure. J Clin Microbiol 1998 0.81
170 The bacteriology of chronic destructive pneumonia. S Afr Med J 1978 0.81
171 Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae. J Clin Microbiol 1999 0.81
172 In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds. Antimicrob Agents Chemother 1998 0.81
173 Synergic activity, for anaerobes, of trovafloxacin with clindamycin or metronidazole: chequerboard and time-kill methods. J Antimicrob Chemother 2000 0.80
174 Salmonella typhi meningitis in children: report of 7 cases. Trans R Soc Trop Med Hyg 1979 0.80
175 Pasteurella multocida septicaemia complicating Felty's syndrome: A case report. S Afr Med J 1980 0.79
176 Postantibiotic effect of tigecycline against 14 gram-positive organisms. Antimicrob Agents Chemother 2008 0.79
177 Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis. Antimicrob Agents Chemother 1998 0.79
178 Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis. Antimicrob Agents Chemother 1999 0.79
179 Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organisms. Diagn Microbiol Infect Dis 1998 0.79
180 Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagn Microbiol Infect Dis 1997 0.79
181 Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes. Clin Microbiol Infect 2005 0.78
182 Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin. Clin Microbiol Infect 2002 0.78
183 Intra-abdominal abscess and fungemia caused by candida krusei. Arch Intern Med 1980 0.78
184 In vitro development of resistance to ceftriaxone, cefprozil and azithromycin in Streptococcus pneumoniae. J Antimicrob Chemother 2000 0.78
185 Evaluation of the Micro-ID, the API 20E and the Rapid 20E for same-day identification of Enterobacteriaceae. Eur J Clin Microbiol 1985 0.78
186 Characteristics and management of chronic destructive pneumonia. Thorax 1980 0.78
187 Ecology of Proteus flagellar phages. Arch Mikrobiol 1973 0.77
188 Studies on the growth-inhibiting property of amniotic fluids from two United States population groups. Am J Obstet Gynecol 1980 0.77
189 Intestinal bacteria in patients with tropical sprue. S Afr Med J 1980 0.77
190 Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1995 0.77
191 Reduction of oral flora with rifampin in healthy volunteers. Antimicrob Agents Chemother 1986 0.77
192 Skin preparation methods before cesarean section. A comparative study. J Reprod Med 1988 0.77
193 Chorioamnionitis and possible neonatal infection associated with Lactobacillus species. J Clin Microbiol 1982 0.76
194 Antibacterial activity of amniotic fluid in the early third trimester. Its association with preterm labor and delivery. Am J Perinatol 1987 0.76
195 The effect of amniotic fluid on bacterial growth in three population groups. Am J Obstet Gynecol 1977 0.76
196 Arthritis caused by unidentified gram-positive rods in a child with acute lymphocytic leukemia. J Clin Microbiol 1982 0.76
197 Abortive transuction of motility in Proteus and Providence strains. J Gen Microbiol 1972 0.76
198 Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile. Int J Antimicrob Agents 2002 0.76
199 Changing patterns of infections in patients with multiple myeloma. Oncology 1982 0.76
200 Neonatal sepsis due to group G streptococci. Acta Paediatr Scand 1980 0.76
201 Postoperative wound infection associated with Vibrio parahaemolyticus in a patient without exposure to seawater. J Clin Microbiol 1988 0.75
202 Incidence of infections with Salmonella enteritidis serotypes in Black and Indian children. A 16-year survey. S Afr Med J 1978 0.75
203 Tinidazole in the prophylaxis and treatment of anaerobic infection. Chemotherapy 1980 0.75
204 Agar medium for gas-liquid chromatography of anaerobes. Am J Clin Pathol 1986 0.75
205 In vitro activity of YTR 830. J Chemother 1989 0.75
206 Absence of hepatitis B antigens from feces and sewage as a result of enzymatic destruction. J Infect Dis 1975 0.75
207 Activity of trovafloxacin, alone and in combination with other agents, against Enterobacteriaceae by time-kill analysis. Eur J Clin Microbiol Infect Dis 2000 0.75
208 Role of anaerobes in recurrent subcutaneous abscesses. Lancet 1981 0.75
209 In vitro anti-anaerobic activity of the cephalosporin derivative RWJ 54428, compared to seven other compounds. Clin Microbiol Infect 2002 0.75
210 In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia. Eur J Clin Microbiol Infect Dis 1996 0.75
211 Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. Diagn Microbiol Infect Dis 2001 0.75
212 Pseudoepidemic of endocarditis in patients undergoing open heart surgery. Infect Control 1982 0.75
213 A phage-inhibitor for the swarming of Proteus. J Med Microbiol 1972 0.75
214 A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin. S Afr Med J 1977 0.75
215 Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study. Clin Microbiol Infect 2006 0.75
216 Thyroid abscess associated with Eikenella corrodens in a 7-year-old child. Clin Pediatr (Phila) 1982 0.75
217 Pseudomonas paucimobilis empyema after cardiac transplantation. South Med J 1988 0.75
218 Group C streptococcal meningitis. Mayo Clin Proc 1978 0.75
219 Anaerobic infections in hospital practice. S Afr Med J 1976 0.75
220 Letter: Indole-negative Escherichia coli strains. S Afr Med J 1976 0.75
221 Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococci. Drugs 1995 0.75
222 Vascular prosthetic infection with Staphylococcus epidermidis: experimental study of pathogenesis and therapy. J Vasc Surg 1989 0.75
223 Mortality-associated factors in infected lymphoma patients. Cancer 1987 0.75
224 Antipneumococcal activity of MEN 10700, a new penem, compared with other compounds, by MIC and time-kill kinetics. J Antimicrob Chemother 1999 0.75
225 Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methods. J Antimicrob Chemother 2000 0.75
226 Multiply resistant pneumococci in The Netherlands. Eur J Clin Microbiol Infect Dis 1994 0.75
227 Colonization of nasal ulcers as a source of Candida parapsilosis fungemia. Arch Otolaryngol 1980 0.75
228 The incidence of penicillin-resistant pneumococci in the Slovak Republic. Pneumococcus Study Group. Chemotherapy 1997 0.75
229 Differentiation between mitochondrial antibodies and other auto-antibodies. S Afr Med J 1977 0.75